OrbiMed Advisors LLC

Investor type

PE

Founded

1989

AUM

$18 000 M

Location

New York, New York, United States

$10-50 m

Investment Ticket

3-5 years

Investment Horizon

Series B, Late Stage (Series C+)

Investment Stage

Sale to strategic investor, IPO

Exit Strategy

Investor profile last updated: 27 July, 2026

Profile

OrbiMed invests globally across the healthcare industry, from start-ups to large multinational corporations, through a range of private equity funds, public equity funds, and royalty/credit funds. OrbiMed seeks to be a capital provider of choice, providing tailored financing solutions and extensive global team resources to help build world-class healthcare companies. OrbiMed’s team of over 100 professionals is based in New York City, San Francisco, Shanghai, Hong Kong, Mumbai, Herzliya, and other key global markets.

Industry

Biotechnology Healthcare Services Medical Devices Other SaaS Security Software HealthTech Food and Beverage Foodtech Media and Entertainment Marketing and Advertising

Region of investment

North America South America Europe Middle East Africa Asia Australia and others

OrbiMed Advisors LLC Funds

Name Type
Questionare
Industry
Questionare
Stage
Questionare
Region
Size AUM Launch date
OrbiMed Private Investments VIII
Venture Capital (VC)
Food and Beverage
Foodtech
Healthcare Services
SaaS
Security
Software
HealthTech
Seed
North America
Asia
$5-10 m
$1500 M
March 2025
OrbiMed Asia Partners V
Venture Capital (VC)
Food and Beverage
Foodtech
Healthcare Services
Media and Entertainment
HealthTech
Seed
North America
Asia
$5-10 m
$751 M
October 2023
OrbiMed Private Investments IX
Private Equity (PE)
Food and Beverage
Foodtech
Healthcare Services
Media and Entertainment
SaaS
Security
Software
HealthTech
Series B
North America
Europe
Asia
$5-10 m
$1900 M
October 2023
OrbiMed Royalty and Credit Opportunities Fund V
Fund of funds
Food and Beverage
Foodtech
Healthcare Services
SaaS
Security
Software
HealthTech
Seed
Series A
Series B
North America
Middle East
Asia
$5-10 m
$1900 M
August 2025
OrbiMed Royalty and Credit Opportunities IV
Fund of funds
Food and Beverage
Foodtech
Healthcare Services
Marketing and Advertising
SaaS
Security
Software
HealthTech
Seed
Series A
Series B
North America
Europe
Asia
$5-10 m
$1700 M
October 2023

Contacts

Upgrade to see contacts
Name
Title
Email
avatar
148PqKQcAjBGRv0D 148PqKQcAjBGRv0D
148PqKQcAjBGRv0D
avatar
148PqKQcAjBGRv0D 148PqKQcAjBGRv0D
148PqKQcAjBGRv0D
avatar
148PqKQcAjBGRv0D 148PqKQcAjBGRv0D
148PqKQcAjBGRv0D
avatar
148PqKQcAjBGRv0D 148PqKQcAjBGRv0D
148PqKQcAjBGRv0D
avatar
148PqKQcAjBGRv0D 148PqKQcAjBGRv0D
148PqKQcAjBGRv0D
If there are no contacts of this investor, please write to us, we will try to find them as soon as possible and get back to you!

FAQs about OrbiMed Advisors LLC

OrbiMed Advisors LLC is located in New York, New York, United States.
OrbiMed Advisors LLC was founded in 1989.
OrbiMed Advisors LLC invests in companies and startups in Biotechnology, Healthcare Services, Medical Devices, Other, SaaS, Security, Software, HealthTech, Food and Beverage, Foodtech, Media and Entertainment, Marketing and Advertising.
OrbiMed Advisors LLC invests in companies and startups in North America, South America, Europe, Middle East, Africa, Asia, Australia and others.
OrbiMed Advisors LLC invests in companies and startups at Series B, Late Stage (Series C+).
OrbiMed Advisors LLC usually invests $10-50 m on average.
OrbiMed Advisors LLC has around $18 000m assets under management.
OrbiMed Advisors LLC last fund was created/launched in 2025-08-26